Literature DB >> 19184978

Cell proteomic footprint.

Petr Lokhov1, Elena Balashova, Maxim Dashtiev.   

Abstract

The authentication of mammalian cell cultures and their subpopulations is of great demand in biotechnology and cell therapy. However, current techniques are either not efficient or can be very complex and expensive. Here we report a simple and straightforward approach for authentication of biological cells and their subpopulations with high speed, high throughput, low sample cost, and high sensitivity. We discovered that cell cultures treated with protease under soft, 'non-killing' conditions release fragments of cell surface proteins, whose composition is a strong characteristic of the cells. Mass spectrometric analysis of the released fragments allows a direct comparison of the produced mass spectrum with the mass spectrum of known cells. As an example, we applied this technique to verify subpopulations of human fibroblasts with different origins and which exhibit different medical characteristics. John Wiley & Sons, Ltd

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19184978     DOI: 10.1002/rcm.3928

Source DB:  PubMed          Journal:  Rapid Commun Mass Spectrom        ISSN: 0951-4198            Impact factor:   2.419


  10 in total

Review 1.  Metabolomics Community in Russia: History of Development, Key Participants, and Results.

Authors:  Elena E Balashova; Dmitry L Maslov; Oxana P Trifonova
Journal:  BioTech (Basel)       Date:  2020-10-25

2.  Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Cancer       Date:  2010-11-29       Impact factor: 4.207

3.  Proteomic footprinting of drug-treated cancer cells as a measure of cellular vaccine efficacy for the prevention of cancer recurrence.

Authors:  Elena E Balashova; Maxim I Dashtiev; Petr G Lokhov
Journal:  Mol Cell Proteomics       Date:  2011-11-09       Impact factor: 5.911

Review 4.  Design of universal cancer vaccines using natural tumor vessel-specific antigens (SANTAVAC).

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Allogeneic Antigen Composition for Preparing Universal Cancer Vaccines.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  J Immunol Res       Date:  2016-10-03       Impact factor: 4.818

6.  SANTAVAC ™: A Novel Universal Antigen Composition for Developing Cancer Vaccines.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Recent Pat Biotechnol       Date:  2017

7.  Changing Landscape of Cancer Vaccines-Novel Proteomics Platform for New Antigen Compositions.

Authors:  Petr G Lokhov; Steven Lichtenberg; Elena E Balashova
Journal:  Int J Mol Sci       Date:  2022-04-15       Impact factor: 6.208

8.  Tumor-induced endothelial cell surface heterogeneity directly affects endothelial cell escape from a cell-mediated immune response in vitro.

Authors:  Petr G Lokhov; Elena E Balashova
Journal:  Hum Vaccin Immunother       Date:  2013-01       Impact factor: 3.452

9.  Multivariate Calibration Approach for Quantitative Determination of Cell-Line Cross Contamination by Intact Cell Mass Spectrometry and Artificial Neural Networks.

Authors:  Elisa Valletta; Lukáš Kučera; Lubomír Prokeš; Filippo Amato; Tiziana Pivetta; Aleš Hampl; Josef Havel; Petr Vaňhara
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

Review 10.  SANTAVACTM: Summary of Research and Development.

Authors:  Petr G Lokhov; Mikayel Mkrtichyan; Grigor Mamikonyan; Elena E Balashova
Journal:  Vaccines (Basel)       Date:  2019-11-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.